de Vanguard Group HCA Healthcare HCA Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | USD 6870 M | Vender |
14,716,173
-178,502
| -1% | -USD 82.9 M | 0.1% | 176 |
|
|
2025
Q3 | USD 6348 M | Vender |
14,894,675
-580,889
| -4% | -USD 225 M | 0.1% | 191 |
|
|
2025
Q2 | USD 5929 M | Vender |
15,475,564
-276,005
| -2% | -USD 99.5 M | 0.1% | 192 |
|
|
2025
Q1 | USD 5443 M | Vender |
15,751,569
-76,857
| -0.5% | -USD 24.7 M | 0.1% | 193 |
|
|
2024
Q4 | USD 4751 M | Vender |
15,828,426
-189,518
| -1% | -USD 66.2 M | 0.08% | 225 |
|
|
2024
Q3 | USD 6510 M | Vender |
16,017,944
-821,571
| -5% | -USD 301 M | 0.12% | 153 |
|
|
2024
Q2 | USD 5410 M | Vender |
16,839,515
-150,168
| -0.9% | -USD 48.8 M | 0.1% | 167 |
|
|
2024
Q1 | USD 5667 M | Comprar |
16,989,683
+60,304
| +0.4% | +USD 18.4 M | 0.11% | 163 |
|
|
2023
Q4 | USD 4582 M | Vender |
16,929,379
-200,238
| -1% | -USD 49.5 M | 0.1% | 185 |
|
|
2023
Q3 | USD 4214 M | Vender |
17,129,617
-352,641
| -2% | -USD 96.5 M | 0.1% | 183 |
|
|
2023
Q2 | USD 5306 M | Vender |
17,482,258
-406,436
| -2% | -USD 113 M | 0.13% | 139 |
|
|
2023
Q1 | USD 4717 M | Vender |
17,888,694
-58,024
| -0.3% | -USD 14.7 M | 0.12% | 151 |
|
|
2022
Q4 | USD 4306 M | Vender |
17,946,718
-141,715
| -0.8% | -USD 31.7 M | 0.12% | 174 |
|
|
2022
Q3 | USD 3324 M | Vender |
18,088,433
-528,820
| -3% | -USD 105 M | 0.1% | 209 |
|
|
2022
Q2 | USD 3129 M | Vender |
18,617,253
-496,245
| -3% | -USD 107 M | 0.09% | 230 |
|
|
2022
Q1 | USD 4790 M | Comprar |
19,113,498
+181,855
| +1% | +USD 45.7 M | 0.11% | 170 |
|
|
2021
Q4 | USD 4864 M | Vender |
18,931,643
-1,055,035
| -5% | -USD 258 M | 0.11% | 168 |
|
|
2021
Q3 | USD 4851 M | Vender |
19,986,678
-997,934
| -5% | -USD 244 M | 0.12% | 146 |
|
|
2021
Q2 | USD 4338 M | Vender |
20,984,612
-30,265
| -0.1% | -USD 6.17 M | 0.11% | 170 |
|
|
2021
Q1 | USD 3958 M | Comprar |
21,014,877
+228,351
| +1% | +USD 40.3 M | 0.11% | 166 |
|
|
2020
Q4 | USD 3419 M | Vender |
20,786,526
-84,374
| -0.4% | -USD 12.3 M | 0.1% | 189 |
|
|
2020
Q3 | USD 2602 M | Vender |
20,870,900
-134,016
| -0.6% | -USD 16.6 M | 0.09% | 221 |
|
|
2020
Q2 | USD 2039 M | Vender |
21,004,916
-405,682
| -2% | -USD 42.2 M | 0.07% | 288 |
|
|
2020
Q1 | USD 1924 M | Comprar |
21,410,598
+417,842
| +2% | +USD 54.1 M | 0.08% | 239 |
|
|
2019
Q4 | USD 3103 M | Comprar |
20,992,756
+62,510
| +0.3% | +USD 8.39 M | 0.11% | 188 |
|
|
2019
Q3 | USD 2520 M | Comprar |
20,930,246
+65,225
| +0.3% | +USD 8.43 M | 0.09% | 226 |
|
|
2019
Q2 | USD 2820 M | Comprar |
20,865,021
+88,231
| +0.4% | +USD 11.2 M | 0.11% | 188 |
|
|
2019
Q1 | USD 2709 M | Comprar |
20,776,790
+183,284
| +0.9% | +USD 24.6 M | 0.11% | 184 |
|
|
2018
Q4 | USD 2563 M | Comprar |
20,593,506
+677,146
| +3% | +USD 90.9 M | 0.12% | 171 |
|
|
2018
Q3 | USD 2771 M | Comprar |
19,916,360
+66,808
| +0.3% | +USD 8.32 M | 0.11% | 178 |
|
|
2018
Q2 | USD 2037 M | Comprar |
19,849,552
+475,507
| +2% | +USD 48.1 M | 0.09% | 237 |
|
|
2018
Q1 | USD 1879 M | Comprar |
19,374,045
+56,951
| +0.3% | +USD 5.53 M | 0.08% | 252 |
|
|
2017
Q4 | USD 1697 M | Vender |
19,317,094
-350,755
| -2% | -USD 28.2 M | 0.07% | 297 |
|
|
2017
Q3 | USD 1565 M | Vender |
19,667,849
-50,401
| -0.3% | -USD 4.05 M | 0.07% | 302 |
|
|
2017
Q2 | USD 1719 M | Comprar |
19,718,250
+141,258
| +0.7% | +USD 12 M | 0.08% | 253 |
|
|
2017
Q1 | USD 1742 M | Comprar |
19,576,992
+361,027
| +2% | +USD 30.1 M | 0.09% | 241 |
|
|
2016
Q4 | USD 1422 M | Vender |
19,215,965
-387,412
| -2% | -USD 29 M | 0.08% | 272 |
|
|
2016
Q3 | USD 1483 M | Vender |
19,603,377
-35,387
| -0.2% | -USD 2.71 M | 0.09% | 249 |
|
|
2016
Q2 | USD 1512 M | Vender |
19,638,764
-27,883
| -0.1% | -USD 2.2 M | 0.09% | 233 |
|
|
2016
Q1 | USD 1535 M | Comprar |
19,666,647
+1,053,560
| +6% | +USD 73.6 M | 0.1% | 213 |
|
|
2015
Q4 | USD 1259 M | Comprar |
18,613,087
+84,850
| +0.5% | +USD 5.92 M | 0.08% | 253 |
|
|
2015
Q3 | USD 1433 M | Comprar |
18,528,237
+1,524,514
| +9% | +USD 135 M | 0.1% | 201 |
|
|
2015
Q2 | USD 1543 M | Comprar |
17,003,723
+197,574
| +1% | +USD 15.8 M | 0.1% | 196 |
|
|
2015
Q1 | USD 1264 M | Comprar |
16,806,149
+4,776,247
| +40% | +USD 343 M | 0.09% | 255 |
|
|
2014
Q4 | USD 883 M | Comprar |
12,029,902
+433,467
| +4% | +USD 30.5 M | 0.06% | 344 |
|
|
2014
Q3 | USD 818 M | Comprar |
11,596,435
+150,085
| +1% | +USD 9.9 M | 0.06% | 334 |
|
|
2014
Q2 | USD 645 M | Comprar |
11,446,350
+478,421
| +4% | +USD 25.2 M | 0.05% | 424 |
|
|
2014
Q1 | USD 576 M | Comprar |
10,967,929
+300,458
| +3% | +USD 15 M | 0.05% | 438 |
|
|
2013
Q4 | USD 509 M | Comprar |
10,667,471
+1,805,142
| +20% | +USD 83.4 M | 0.04% | 465 |
|
|
2013
Q3 | USD 379 M | Comprar |
8,862,329
+352,350
| +4% | +USD 13.8 M | 0.04% | 533 |
|
|
2013
Q2 | USD 307 M | Comprar |
+8,509,979
| Nuevas | +USD 329 M | 0.03% | 579 |
|
Otros fondos que tienen HCA en su cartera
Posición de Vanguard Group en HCA: resumen de T4 2025
Vanguard Group redujo su participación en HCA Healthcare (HCA) en 1.2% durante T4 2025, al vender acciones por un valor estimado de USD 82.9 M, y conservó 14,716,173 acciones valuadas en USD 6870 M. La posición representa 0.1% de la cartera y ocupa el puesto #176.
Vanguard Group reportó por primera vez una posición en HCA en T2 2013 y la ha mantenido durante 51 trimestres desde entonces. Al cierre de T4 2025, 1,403 fondos que sigue Wall St. Rank mantienen una posición en HCA.
- Al cierre de T4 2025, Vanguard Group tenía 14,716,173 acciones de HCA Healthcare con un valor de USD 6870 M.
- Vanguard Group vendió 178,502 acciones de HCA Healthcare en T4 2025, por un valor estimado de USD 82.9 M.
- HCA Healthcare representó 0.1% de la cartera de Vanguard Group en T4 2025 y fue su posición número 176.
- Vanguard Group reportó por primera vez una posición en HCA Healthcare en T2 2013 y la ha mantenido durante 51 trimestres desde entonces.
- Al cierre de T4 2025, 1,403 fondos que sigue Wall St. Rank tenían HCA Healthcare en cartera.
Según el Informe 13F de Vanguard Group correspondiente a T4 2025, presentado el 29 ene 2026.